American Healthcare REIT Receives Low Valuation Grades
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 02 2024
0mins
American Healthcare REIT Inc. has seen a significant price drop, hitting a 20-day low amid broader market gains.
The recent valuation grades from Seeking Alpha indicate that American Healthcare REIT received an F rating, highlighting its lack of attractiveness compared to sector peers. This low rating suggests extremely low investment appeal, which may hinder its future financing capabilities.
The implications of this rating could lead to increased scrutiny from investors, as the overall market confidence in mid-cap REITs remains suppressed, particularly in the current economic environment.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AHR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AHR
Wall Street analysts forecast AHR stock price to rise
12 Analyst Rating
11 Buy
1 Hold
0 Sell
Strong Buy
Current: 46.820
Low
47.00
Averages
55.25
High
60.00
Current: 46.820
Low
47.00
Averages
55.25
High
60.00
About AHR
American Healthcare REIT, Inc. is a self-managed real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate properties, focusing primarily on senior housing, skilled nursing facilities (SNFs), outpatient medical (OM), buildings and other healthcare-related facilities. It owns and operates its integrated senior health campuses (ISHC) and senior housing operating properties (SHOP). Its segments include ISHC, OM, SHOP and triple-net leased properties. ISHC segment provides a range of independent living, assisted living, memory care, skilled nursing services and certain ancillary businesses. OM segment includes buildings that are leased to multiple tenants under separate leases. SHOP segment includes senior housing, which offers assisted living care, independent living, memory care or skilled nursing services. Its triple-net leased properties segment includes senior housing, skilled nursing facilities and hospital investments.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Jobs Data Impact: The unexpected addition of 172,000 jobs in May 2026 raised concerns among investors about the Federal Reserve maintaining high interest rates, leading to a sharp market retreat that highlights the tension between economic resilience and high-rate anxiety.
- Geopolitical Tensions Escalate: Renewed missile exchanges between Iran and Israel threaten the stability of the April ceasefire, adding to market uncertainty, particularly regarding maritime security in the critical Strait of Hormuz.
- Low-Leverage Stock Recommendations: In light of high volatility, investors are advised to consider low-leverage companies such as HF Sinclair, Siemens Energy, American Healthcare REIT, Par Pacific, and Green Dot to navigate interest rate fluctuations and geopolitical risks effectively.
- Financial Leverage Risk Analysis: Investors should monitor the debt-to-equity ratios of companies, as lower ratios typically indicate better solvency; selecting low-leverage firms can help ensure steady returns during economic downturns.
See More
- Valuation Overview: Seeking Alpha's valuation grades reveal that U.S. mid-cap REITs, with market capitalizations between $2B and $10B, exhibit several companies with high valuation levels, indicating a lack of attractiveness compared to sector peers.
- Least Attractive Stocks: Companies such as American Healthcare REIT (AHR), Curbline Properties (CURB), Janus Living (JAN), and Terreno Realty (TRNO) received an F rating, suggesting extremely low investment appeal in the current market, which may hinder their future financing capabilities.
- Mid-Cap REIT Performance: First Industrial Realty Trust (FR), Fermi Inc. (FRMI), Vornado Realty Trust (VNO), Acadia Realty Trust (AKR), and InvenTrust Properties (IVT) all received a D rating, indicating insufficient competitiveness in the market and potential increased market pressure.
- Future Outlook: While Macerich has set a 2028 FFO target of $1.80 to $2.00 per share, overall market confidence in mid-cap REITs is suppressed, particularly in the current economic environment, prompting investors to carefully assess these companies' long-term potential.
See More
- Offering Size: American Healthcare REIT announced a public offering of 14 million shares of common stock, expected to generate approximately $705.6 million in gross proceeds, with a closing date set for May 22, 2026, indicating the company's proactive approach to capital markets.
- Underwriter Role: BofA Securities acts as the underwriter for the offering and has been granted a 30-day option to purchase an additional 2.1 million shares, which could further enhance the company's capital structure and liquidity if exercised.
- Forward Sale Agreement: The company entered into a forward sale agreement with BofA Securities, expecting to settle within 24 months, and if the underwriter's option is fully exercised, the total shares could increase to 16.1 million, thereby boosting the company's financing capabilities in the market.
- Planned Use of Proceeds: The company intends to contribute the net proceeds from the forward sale agreement to its operating partnership, highlighting its focus on future investment opportunities and aiming to enhance overall business growth potential.
See More
- Offering Size: American Healthcare REIT announced a public offering of 14 million shares at approximately $50.4 per share, expecting gross proceeds of about $705.6 million, reflecting strong market demand and investor confidence in the company.
- Underwriting Arrangement: BofA Securities acts as the underwriter and has been granted a 30-day option to purchase an additional 2.1 million shares, a flexible underwriting strategy that may enhance the company's liquidity and market adaptability.
- Use of Proceeds: The company intends to contribute the net proceeds from the offering to its operating partnership for general corporate purposes and future investments, indicating a proactive approach to business expansion and strategic planning.
- Market Impact: The successful pricing and imminent closing of this offering are expected to bolster the company's market position in the healthcare real estate sector, strengthening its capital structure and laying the groundwork for future growth.
See More
- Public Offering Launch: American Healthcare REIT (AHR) announced the launch of an underwritten public offering of 14 million shares of common stock through a forward sale agreement, which is expected to provide funding for future investments.
- Additional Share Option: The underwriter is expected to receive a 30-day option to purchase up to an additional 2.1 million shares, enhancing market liquidity and providing more opportunities for investors.
- Clear Use of Proceeds: The company stated it expects to settle the forward sale agreement within about 24 months, with net proceeds intended for general corporate purposes, including potential future investments, demonstrating its strategic planning for business expansion.
- Future Performance Guidance: American Healthcare REIT also outlined its 2026 NFFO per share guidance of $2.03 to $2.09, with same-store NOI growth target raised to 9%-12%, reflecting the company's confidence in future growth.
See More
- Consistent Same-Store NOI Growth: American Healthcare REIT achieved a same-store NOI growth of 12.1% in Q1 2026, marking the ninth consecutive quarter of double-digit growth, which underscores the company's robust performance in core operations and is likely to enhance investor confidence.
- Strong SHOP Segment Performance: The SHOP segment reported a remarkable same-store NOI growth of 19.7% in Q1, with $249.2 million in acquisitions, indicating the company's advantageous position in the rapidly growing healthcare real estate market and driving future revenue growth.
- Improved Financial Health: As of March 31, 2026, the company's net debt to annualized EBITDA ratio improved to 3.0x, down from 3.4x at the end of 2025, demonstrating effective financial management that could enhance credit ratings and financing capabilities.
- Optimistic Outlook: Management raised the 2026 same-store NOI growth guidance to 9% to 12% and increased the NFFO per share guidance to $2.03 to $2.09, reflecting confidence in future market demand and likely attracting more investor interest.
See More









